Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1Phase 1/2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 2Uterine Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Glioblastoma 1Endometrial Neoplasms 1Cystadenocarcinoma, Serous 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 6Radiotherapy 6fluciclovine F-18 4Topotecan 4fluorodopa F 18 3Biopsy 3niraparib 2abemaciclib 2Standard of Care 2Specimen Handling 2Pemetrexed 2Ketoconazole 2ulixertinib 1temsirolimus 1ribociclib 1posaconazole 1poly ICLC 1pitavastatin 1pembrolizumab 1orludodstat 1lorlatinib 1larotrectinib 1infigratinib 1fisetin 1fimepinostat 1evolocumab 1clevudine 1X-Rays 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioma × niraparib × Clear all
NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Active not recruiting
42 enrolled
CNS

Glioblastoma, Glioma

NCT05406700 2026-02-09

Niraparib In Recurrent IDH 1/2 Gliomas

Massachusetts General Hospital

Phase EARLY_PHASE1 Active not recruiting
16 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡